CONCLUSION
In conclusion, 47.3 % of ICU patients at MM had a clinically
significant DDIs, and ICU patients at MM had lower rates of DDIs than
patients at KTH, likely due to the presence of EMR based screening.
Additional studies at a variety of units and institutions are needed to
determine the relative effectiveness of EMR-based screening tools and
pharmacists. Outcome studies are also needed to validate that clinically
relevant DDIs have meaningful effects on patient outcomes. Finally,
improvements are needed to EMR-based DDI screening tools and systems to
detect and manage DDIs to ensure all patients receive safe and effective
treatment.